Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M216Revenue (TTM) $M32.8Net Margin (%)-250.9Altman Z-Score1.2
Enterprise Value $M98.5EPS (TTM) $-2.8Operating Margin %-263.7Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-263.2Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %--Quick Ratio5.1Cash flow > EarningsY
Price/Sales6.65-y EBITDA Growth Rate %--Current Ratio5.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-46.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-58.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NLNK

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

NLNK is held by these investors:



NLNK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Langren Carl W.Principal Accounting Officer 2016-12-14Sell3,943$10.85-31.8view
Talarico Ernest IIIDirector 2016-06-06Buy4,065$12.32-39.94view
Link Charles J. Jr.Chairman of the Board and CEO 2016-04-07Sell10,000$20.03-63.06view
Link Charles J. Jr.Chairman of the Board and CEO 2016-03-15Sell25,000$17.86-58.57view
Link Charles J. Jr.Chairman of the Board and CEO 2016-02-03Sell25,000$24.16-69.37view
HENNEMAN JOHN B IIIEVP, CFO 2016-01-05Sell175$35.74-79.29view
Wiley BrianVP of Business Development 2016-01-05Sell1,295$34.99-78.85view
Vahanian Nicholas N.President, Chief Medical Offic 2016-01-05Sell3,011$35.06-78.89view
Vahanian Nicholas N.President, Chief Medical Offic 2015-09-11Sell10,000$51.19-85.54view
Vahanian Nicholas N.President, Chief Medical Offic 2015-08-03Sell10,000$51.77-85.71view

Press Releases about NLNK :

Quarterly/Annual Reports about NLNK:

News about NLNK:

Articles On GuruFocus.com
NewLink Genetics to Regain Rights to GDC-0919 Jun 08 2017 
Results from Clinical Trial of Indoximod Plus Chemotherapy for Patients with Metastatic Breast Cance Jun 02 2017 
NewLink Genetics to Participate in Upcoming Investor Conferences May 08 2017 
NewLink Genetics Reports First Quarter 2017 Financial Results and Updates Clinical Trial Guidance May 04 2017 
Lifshitz & Miller LLP Announces Investigation of Bingo Nation Inc., BofI Holding, Inc., Corbus Pharm May 03 2017 
NewLink Genetics Announces Presentation of Two Abstracts at ASCO Apr 21 2017 
NewLink Genetics to Host Its First Quarter 2017 Financial Results Conference Call on May 4, 2017 Apr 13 2017 
Interim Phase 2 Data Demonstrate Robust Response Rate with Indoximod in Combination with Keytruda Apr 04 2017 
NewLink Genetics Announces Presentation of Two Abstracts at AACR Mar 01 2017 
First Eagle Investment Adds to Stake in NewLink Genetics Feb 03 2016 

More From Other Websites
These 3 Biotechs Have Been Crushed; Is It Time to Bargain Shop? Jun 21 2017
A Surprising Disappointment Derails NewLink Genetics -- What's Next? Jun 19 2017
Are Options Traders Betting on a Big Move in NewLink (NLNK) Stock? Jun 13 2017
Roche-NewLink Drug Move Shouldn't Impact Incyte, Says Analyst Jun 09 2017
Why Sina, Eldorado Gold, and NewLink Genetics Slumped Today Jun 08 2017
Stocks Pull Off Narrow Win, But These Four Soared To New Highs Jun 08 2017
Why Is NewLink Genetics Losing One-Third of Its Value Today? Jun 08 2017
NewLink Genetics Sinks After Regaining Licensing Rights for Its Cancer Treatment Jun 08 2017
Biotech Movers: NewLink, Inovio, Juno Jun 08 2017
NewLink Genetics' stock plunges as Genentech plans to returns rights cancer treatment candidate Jun 08 2017
NewLink Genetics to Regain Rights to GDC-0919 Jun 08 2017
Why Herbalife, JinkoSolar, and NewLink Genetics Slumped Today Jun 05 2017
Biotech Movers: Loxo, NewLink, BioCryst Jun 05 2017
NewLink Genetics’ Indoximod + PROVENGE® Results in Statistically Significant Improvement in... Jun 05 2017
Results from Clinical Trial of Indoximod Plus Chemotherapy for Patients with Metastatic Breast... Jun 02 2017
Cancer drug prices could double or triple thanks to this popular but unproven drug trend Jun 02 2017
Update in Lawsuit for Investors in NewLink Genetics Corp (NASDAQ: NLNK) Shares Announced by... May 30 2017
Incyte Teams Up With Dow's Merck To Trounce Roche In Cancer May 18 2017
Biotech Stocks: Is ASCO Much Ado About Nothing? May 18 2017
Data from Clinical Study of NewLink Genetics’ IDO Pathway Inhibitor, Indoximod, to Be Presented at... May 18 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}